Direct activation of human CD8+ cytotoxic T lymphocytes by interleukin-18

Japanese Journal of Cancer Research

Volumn 89, Issue 10, 1998, Pages 1041-1046

  Kohyama, Masako ^a   Saijyo, Kaoru ^a   Hayasida, Midori ^a   Yasugi, Tomoko ^a   Kurimoto, Masashi ^b   Ohno, Tadao ^a  

^a RIKEN   (Japan)

^b HAYASHIBARA BIOCHEMICAL LABORATORIES INC   (Japan)

Author keywords

Adoptive immunotherapy; Cytotoxic T lymphocytes; IL 18

Indexed keywords

CD8 ANTIGEN; CYTOKINE; INTERLEUKIN 1; INTERLEUKIN 18; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; UNCLASSIFIED DRUG;

ARTICLE; CELL MEDIATED CYTOTOXICITY; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; HUMAN; HUMAN CELL; MONONUCLEAR CELL; NATURAL KILLER CELL; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; TUMOR CELL;

EID: 0031757553     PISSN: 09105050     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1349-7006.1998.tb00494.x     Document Type: Article

References (25)

1. Yamasaki, T., Handa, H., Yamashita, J., Watanabe, Y., Namba, Y. and Hanaoka, M. Specific adoptive immunotherapy with tumor-specific cytotoxic T-lymphocyte clone for murine malignant gliomas. Cancer Res., 44, 1776-1783 (1984).
2. Rosenberg, S. A., Lotze, M., Muul, T. L., Leitman, M. S., Chang, A. E., Ettinghausen, E. S., Matory, E. Y., Skibber, J. M., Shiloni, E. and Vetto, J. Observation on the systemic administration of autologous lymphokine-activated killer cells and recombinant interleukin-2 to patients with metastatic cancer. N. Engl. J. Med., 313, 1485-1492 (1985).
3. Muul, L. M., Spiess, P. J., Director, E. P. and Rosenberg, S. A. Identification of specific cytolytic immune responses against autologous tumor in humans bearing malignant melanoma. J. Immunol. 138, 989-995 (1987).
4. Topalian, S. L., Muul, L. M., Solomon, D. and Rosenberg, S. A. Expansion of human tumor infiltrating lymphocytes for use in immunotherapy trials. J. Immunol. Methods, 102, 127-141 (1987).
5. Topalian, S. L., Solomon, D. and Rosenberg, S. A. Tumor-specific cytolysis by lymphocytes infiltrating human melanomas. J. Immunol., 142, 3714-3725 (1989).
6. + cytolytic T lymphocytes. Cell. Immunol., 155, 53-61 (1994).
7. Liu, S. Q., Shiba, R., Kim, B. S., Saijo, K. and Ohno, T. Long-term serum/plasma-tree culture of human cytotoxic T lymphocytes induced from peripheral blood mononuclear cells. Cancer Immunol. Immunother., 39, 279-285 (1994).
8. Liu, S. Q., Shiraiwa, H., Kawai, K., Hayashi, H., Akaza, H., Kim, B. S., Oki, A., Nishida, M., Kubo, T., Hashizaki, K., Saijo, K. and Ohno, T. Tumor-specific autologous cytotoxic T lymphocytes from tissue sections. Nat. Med., 2, 1283 (1996).
9. Tsurushima, H., Liu, S. Q., Tsuboi, K., Yoshii, Y., Nose, T. and Ohno, T. Induction of human autologous cytotoxic T lymphocytes against minced tissues of glioblastoma multiforme. J. Neurosurg., 84, 258-263 (1996).
10. Okumura, H., Tsutsui, H., Komatsu, T., Yutsudo, M., Hakura, A., Tanimoto, T., Torigoe, K., Okura, T., Nukada, Y., Hattori, K., Akita, K., Namba, M., Tanabe, F., Konishi, K., Fukuda, S. and Kurimoto, M. Cloning of new cytokine that induces IFN-γ production by T cells. Nature, 378, 88-91 (1995).
11. Ushio, S., Namba, M., Okura, T., Hattori, K., Nukada, Y., Akita, K., Tanabe, F., Konishi, K., Micallef, M., Hujii, M., Torigoe, K., Tanimoto, T., Fukuda, S., Ikeda, M., Okamura, H. and Kurimoto, M. Cloning of the cDNA for human IFN-γ-inducing factor, expression in Escherichia coli, and studies on the biological activities of the protein. J. Immunol., 156, 4274-4279 (1996).
12. Zhang, T., Kawakami, K., Qureshi, M. H., Okamura, H., Kurimoto, M. and Saito, A. Interleukin-12 (IL-12) and IL-18 synergistically induce the fungicidal activity of murine peritoneal exudate cells against Cryptococcus neoformans through production of gamma interferon by natural killer cells. Infect. Immun., 65, 3594-3599 (1997).
13. Dao, T., Ohashi, K., Kayano, T., Kurimoto, M. and Okumura, H. Interferon-γ-inducing factor, a novel cytokine, enhances Fas ligand-mediated cytotoxicity of murine T helper 1 cells. Cell. Immunol., 173, 230-235 (1996).
14. Tsutui, H., Nakanishi, K., Matsui, K., Higashino, K., Okumura, H., Miyazawa, Y. and Kaneda, K. IFN-γ-inducing factor up-regulates Fas ligand-mediated cytotoxic activity of murine natural killer cell clones. J. Immunol., 157, 3967-3973 (1996).
15. Kawai, K., Sasaki, T., Saijo, K. K., Akaza, H., Koiso, K. and Ohno, T. Additive effects of antitumor drugs and lymphokine-activated killer cell cytotoxic activity in tumor cell killing determined by lactate dehydrogenase-release assay. Cancer Immunol. Immunother., 35, 225-229 (1992).
16. Liu, S. Q., Saijo, K., Todoroki, T. and Ohno, T. Induction of human autologous cytotoxic T lymphocytes on formalin-fixed and paraffin-embedded tumour sections. Nat. Med., 1, 267-271 (1995).
17. Micallef, M. J., Tanimoto, T., Kohno, K., Ikeda, M. and Kurimoto, M. Interleukin 18 induces the sequential activation of natural killer cells and cytotoxic T lymphocytes to protect syngeneic mice from transplantation with Meth A sarcoma. Cancer Res., 57, 4557-4563 (1997).
18. + T cells of Tc1 and Tc2 phenotype. Blood, 90, 2089-2096 (1997).
19. Chouaib, S., Chehimi, J., Bani, L., Genetet, N., Tursz, T., Gay, F., Trinchieri, G. and Mami, C. F. Interleukin 12 induces the differentiation of major histocompatibility complex class I-primed cytotoxic T-lymphocyte precursors into allospecific cytotoxic effectors. Proc. Natl. Acad. Sci. USA, 91, 12659-12663 (1994).
20. Kobayashi, M., Fitz, L., Ryan, M., Hewick, R. M., Clark, S. C., Chan, S., Loudon, R., Sherman, F., Perussia, B. and Trinchieri, G. Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes. J. Exp. Med., 170, 827-845 (1989).
21. Wolf, S. F., Temple, P. A., Kobayashi, M., Young, D., Dicig, M., Lowe, L., Dzialo, R., Fitz, L., Ferenz, C., Hewick, R. M., Kelleher, K., Herrmann, S., Clark, H. C., Azzoni, S. L., Chan, H., Trinchieri, S. G. and Perussia, B. Cloning of cDNA for natural killer cell stimulatory factor, a heterodimeric cytokine with multiple biologic effects on T and natural killer cells. J. Immunol., 146, 3074-3081 (1991).
22. Torigoe, K., Ushio, S., Okura, T., Kobayashi, S., Taniai, M., Kunikata, T., Murakami, T., Sanou, O., Kojima, H., Fujii, M., Ohta, T., Ikeda, M., Ikegami, H. and Kurimoto, M. Purification and characterization of the human interleukin-18 receptor. J. Biol. Chem., 272, 25737-25742 (1997).
23. Roth, J. A., Osborne, B. A. and Ames, R. S. Immunoregulatory factors derived from human tumors. II. Partial purification and further immunobiochemical characterization of a human sarcoma-derived immunosuppressive factor expressing HLA-DR and immunoglobulin-related determinants. J. Immunol., 130, 303-308 (1983).
24. Siegel, J. P. Effects of interferon-gamma on the activation of human T lymphocytes. Cell. Immunol., 111, 461-472 (1988).
25. Maraskovsky, E., Chen, W. F. and Shortman, K. IL-2 and IFN-gamma are two necessary lymphokines in the development of cytolytic T cells. J. Immunol., 143, 1210-1214 (1989).